TP53 and neoplasm: In addition, miR-7 inhibited glycolysis in PCa cells and reshaped the acidic tumor microenvironment, and the sensitization effects of miR-7 overexpression were independent of p53 status, suggesting that miR-7 based agents could be developed for PCa patients, regardless of p53 status (21).